T-Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$59.6M

T-Therapeutics is a biotech firm specializing in developing TCR therapeutics for cancer and inflammatory disorders using their proprietary OpTiMus® platform.

Total Funding

$59.6M

Headquarters

Cambridge, United Kingdom

Founded

N/A

Website

t-therapeutics.com

Focus Areas

Biotech

TCR Therapeutics

Cancer Treatment

Inflammatory Disorders

Proprietary OpTiMus® Platform

Spin-off

Investors